GB202020619D0 - Pharmaceutical Profiler Array for use in Personalised Healthcare - Google Patents

Pharmaceutical Profiler Array for use in Personalised Healthcare

Info

Publication number
GB202020619D0
GB202020619D0 GBGB2020619.9A GB202020619A GB202020619D0 GB 202020619 D0 GB202020619 D0 GB 202020619D0 GB 202020619 A GB202020619 A GB 202020619A GB 202020619 D0 GB202020619 D0 GB 202020619D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical
profiler array
personalised healthcare
personalised
healthcare
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2020619.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Randox Laboratories Ltd
Original Assignee
Randox Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Randox Laboratories Ltd filed Critical Randox Laboratories Ltd
Priority to GBGB2020619.9A priority Critical patent/GB202020619D0/en
Publication of GB202020619D0 publication Critical patent/GB202020619D0/en
Priority to PCT/EP2021/086760 priority patent/WO2022136254A1/en
Priority to EP21843633.5A priority patent/EP4267962A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9466—Antidepressants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
GBGB2020619.9A 2020-12-24 2020-12-24 Pharmaceutical Profiler Array for use in Personalised Healthcare Ceased GB202020619D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB2020619.9A GB202020619D0 (en) 2020-12-24 2020-12-24 Pharmaceutical Profiler Array for use in Personalised Healthcare
PCT/EP2021/086760 WO2022136254A1 (en) 2020-12-24 2021-12-20 Pharmaceutical profiler array for use in personalised healthcare
EP21843633.5A EP4267962A1 (en) 2020-12-24 2021-12-20 Pharmaceutical profiler array for use in personalised healthcare

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2020619.9A GB202020619D0 (en) 2020-12-24 2020-12-24 Pharmaceutical Profiler Array for use in Personalised Healthcare

Publications (1)

Publication Number Publication Date
GB202020619D0 true GB202020619D0 (en) 2021-02-10

Family

ID=74532081

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2020619.9A Ceased GB202020619D0 (en) 2020-12-24 2020-12-24 Pharmaceutical Profiler Array for use in Personalised Healthcare

Country Status (3)

Country Link
EP (1) EP4267962A1 (en)
GB (1) GB202020619D0 (en)
WO (1) WO2022136254A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0874242B2 (en) 1997-04-21 2009-06-03 Randox Laboratories Ltd. Device and apparatus for the simultaneous detection of multiple analytes
GB201619823D0 (en) 2016-11-23 2017-01-04 Randox Laboratories Ltd And Teoranta Randox GFAP accumulating stroke
EP3545311B1 (en) 2016-11-23 2024-03-27 Randox Laboratories Ltd Gfap derivatives for stroke diagnostics

Also Published As

Publication number Publication date
EP4267962A1 (en) 2023-11-01
WO2022136254A1 (en) 2022-06-30

Similar Documents

Publication Publication Date Title
EP2010269A4 (en) Microprojection array application with sculptured microprojections for high drug loading
BR112015000441A2 (en) Immunoconjugates, Pharmaceutical Formulation and Treatment Method and Method for Inhibiting Proliferation of a CD22 Positive Cell
BR112012018969A2 (en) electrosurgical array electrosurgical instrument for use in an electrosurgical array and treatment unit for an electrosurgical array
GB0803072D0 (en) Solid pharmaceutical and vaccien dose
DK3117828T3 (en) CELL PROLIFERATION PROCEDURE AND PHARMACEUTICAL MEDICINE FOR TISSUE REPAIR AND REGENERATION
TWI367110B (en) Topical pharmaceutical formulation
EP2184986A4 (en) Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
BRPI1011505A2 (en) kinase inhibitor prodrug forms and their application in therapy
EP2186528A4 (en) Pharmaceutical containing hif-1 alpha and hif-2 alpha expression inhibitor
BRPI1005980A2 (en) therapeutic equipment for treating an individual and computer program product
ATE538652T1 (en) SYNERGISTIC PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF CANCER
SI2041129T1 (en) Human protein-tyrosine phosphatase inhibitors and their pharmaceutical use
BR112012018947A2 (en) pharmaceutical composition for cancer treatment and prevention
BRPI0812064A2 (en) PHARMACEUTICAL FORMULATION, TABLES, AND PROCESS FOR THE PRODUCTION OF A PHARMACEUTICAL FORMULATION
GB0709541D0 (en) Pharmaceutical excipient
GB202103211D0 (en) Pharmaceutical compounds for use in therapy
EP3526195A4 (en) Sulfoxyalkyl organonitro and related compounds and pharmaceutical compositions for use in medicine
WO2015079010A3 (en) Pharmaceutical composition comprising lacosamide and levetiracetam
BRPI0810816A2 (en) MEDICINAL PRODUCT AND METHODS FOR TREATING AUTOIMMUNE AND CANCER DISEASES
IL218517A0 (en) Orthopedic plates for use in the midfoot
DK2341900T3 (en) PHARMACEUTICAL PRODUCT AND TREATMENT
IL218008A (en) Dexanabinol, or a pharmaceutically acceptable salt thereof, for the apoptosis of cancer other than melanoma and use thereof in the manufacture of a medicament for the apoptosis of cancer, other than melanoma and a pharmaceutical composition comprising the same
GB202020619D0 (en) Pharmaceutical Profiler Array for use in Personalised Healthcare
CA203899S (en) Tablet computer
IL297081A (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)